Childhood chordoma is a rare malignant bone tumor that develops from remnants of the notochord — an embryonic structure that forms the foundation of the spine during fetal development. While chordoma is more commonly diagnosed in adults between 40 and 70 years of age, it can occur in children and adolescents. Pediatric chordoma behaves differently from adult forms in certain cases and requires specialized multidisciplinary cancer care.
Chordomas are slow-growing yet locally invasive neoplasms. Most chordomas are located within the axial skeleton and commonly occur in the clivus region of the skull base and the sacrum of the lower spine. As the lesion tends to be deeply seated around sensitive neural and vascular structures, total excision may prove difficult.
Chordomas are cancers that arise from notochordal cells that remain in the spinal cord after its formation. They tend to form along the midline of the body and commonly affect:
In children, skull base chordomas are more common than sacral chordomas. Pediatric cases represent a very small percentage of all bone cancers.
Chordomas are classified as:
Poorly differentiated chordoma tends to be more aggressive and may require more intensive treatment.
It is not entirely known what causes chordoma. The condition arises from the remnants of the notochordal cells that do not disappear after birth. Occasionally, a genetic mutation in the SMARCB1 gene causes chordoma.
Unlike many adult cancers, environmental or lifestyle factors are not linked to childhood chordoma.
Symptoms depend on tumor location and size.
Because these tumors grow slowly, symptoms may progress gradually over months.
Early diagnosis requires imaging and tissue confirmation.
A detailed neurological assessment helps determine cranial nerve or spinal involvement.
MRI is the most important imaging tool. It provides a detailed visualization of tumor extent and involvement of nearby structures.
CT scans are performed to assess bone damage and for surgical planning.
It can be performed to assess metastasis; however, this is less likely to occur initially.
A biopsy is essential for establishing the diagnosis since it involves an examination by cancer specialists to determine:
Because of the tumor location, the biopsy must be carefully planned to avoid spreading tumor cells.
Chordomas lack a conventional staging system, unlike other malignancies. Treatment options will depend upon:
Metastases may develop in the lungs, lymph nodes, or bones in children with a more aggressive tumor.
Management of chordoma in children needs a multidisciplinary approach involving pediatric oncologists, neurosurgeons, orthopedic oncologists, radiation oncologists, and physiatrists.
The main goal is to complete tumor removal while preserving neurological function.
Surgery is the primary treatment.
In the case of skull base tumors, surgery can be carried out using:
In the case of spinal or sacral tumors, surgery can be carried out using:
Complete removal leads to a substantial improvement in survival rates.
Owing to the difficulty in complete removal, radiation therapy is a very important aspect.
Used in children because of its accuracy and minimal damage to surrounding tissues.
It can also be used when proton therapy is unavailable.
Radiation therapy is usually given after surgery to lower the chances of recurrence.
Conventional chemotherapy is not very effective in the case of chordoma.
However, in poorly differentiated chordoma, chemotherapy can be an option, especially in young children.
The studies underway are seeking substances that disrupt signaling pathways involved in chordoma development, following which the medical professionals employ a targeted approach to treat cases of chordoma recurrence and metastasis.
Post-treatment monitoring is critical because patients have a high chance of recurrence.
Follow-up care:
The reason follow-up care is significant is that recurrence may happen several years after primary treatment.
Factors affecting recovery include:
Children may require:
Emotional and psychological support is also important.
Prompt treatment can help overcome these complications.
Prognosis depends on:
Children with completely resected tumors followed by radiation have better outcomes. Poorly differentiated chordoma may have a more aggressive course.
Survival rates are inconsistent, and the risk of recurrence remains a concern.
Because chordoma may recur decades after the initial treatment, a lifetime of follow-up care is advised.
Follow-up includes the following:
The following indicates that immediate medical attention is required in children when:
These symptoms may indicate tumor progression or complications.
Tender Palm Super-Speciality Hospital offers advanced Childhood Chordoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced pediatric neurosurgeons and neuro-oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including en bloc surgical resection, proton beam therapy, and comprehensive oncological management procedures. Our Pediatric Neurosurgery and Neuro-Oncology team has decades of experience in successfully treating Childhood Chordoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com